Cahling Lindah, Berntsson Anders, Bröms Gabriella, Öhrmalm Lars
PRIMA, Stockholm, Sweden.
Karolinska Instituted Stockholm, Sweden.
BJPsych Bull. 2017 Oct;41(5):254-259. doi: 10.1192/pb.bp.116.055483.
To assess the patients' most influential concerns regarding long-acting injectable antipsychotics (LAIs) and mental health professionals' preconceptions about these concerns. For both groups, to assess the level of knowledge about LAIs. This cross-sectional study used semi-structured interviews of patients with schizophrenia or schizoaffective disorder ( = 164), nurses ( = 43) and physicians ( = 20). The mental health professionals overestimated many of the patients' fears of LAIs, and the expressed fears exceeded the actual experiences of patients already on LAIs. Acceptance to switch to LAIs was associated with shorter time from diagnosis. Nurses and patients disclosed limited knowledge of antipsychotics. Physicians and nurses should aim to identify the individual patient's concerns about LAIs in the discussion about choice of antipsychotic treatment early in the course of illness.
评估患者对长效注射用抗精神病药物（LAIs）最关注的问题，以及精神卫生专业人员对这些问题的先入之见。针对这两组人群，评估其对LAIs的了解程度。这项横断面研究采用半结构化访谈，访谈对象包括精神分裂症或分裂情感性障碍患者（n = 164）、护士（n = 43）和医生（n = 20）。精神卫生专业人员高估了患者对LAIs的许多担忧，而所表达的担忧超过了已使用LAIs患者的实际经历。接受改用LAIs与诊断后较短时间相关。护士和患者对抗精神病药物的了解有限。医生和护士应在疾病早期讨论抗精神病药物治疗选择时，致力于识别个体患者对LAIs的担忧。
